Citadel Advisors
MXCT icon

Citadel Advisors’s MaxCyte MXCT Stock Holding History

Citadel Advisors’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.05M Buy
856,318
+523,230
+157% +$521K ﹤0.01% 8074
2026
Q1 		$234K Sell
333,088
-1,155,730
-78% -$1.08M ﹤0.01% 11068
2025
Q4 		$2.31M Buy
1,488,818
+685,752
+85% +$1.1M ﹤0.01% 5643
2025
Q3 		$1.27M Sell
803,066
-225,009
-22% -$391K ﹤0.01% 7028
2025
Q2 		$2.24M Buy
1,028,075
+790,433
+333% +$1.91M ﹤0.01% 5492
2025
Q1 		$649K Sell
237,642
-139,956
-37% -$552K ﹤0.01% 7900
2024
Q4 		$1.57M Buy
377,598
+327,025
+647% +$1.24M ﹤0.01% 6126
2024
Q3 		$197K Buy
50,573
+31,235
+162% +$132K ﹤0.01% 10173
2024
Q2 		$75.8K Sell
19,338
-36,561
-65% -$157K ﹤0.01% 11272
2024
Q1 		$234K Sell
55,899
-79,156
-59% -$372K ﹤0.01% 9991
2023
Q4 		$635K Buy
135,055
+86,981
+181% +$339K ﹤0.01% 7601
2023
Q3 		$150K Buy
48,074
+30,662
+176% +$123K ﹤0.01% 10352
2023
Q2 		$79.9K Sell
17,412
-130,943
-88% -$602K ﹤0.01% 11256
2023
Q1 		$734K Sell
148,355
-1,981,690
-93% -$9.76M ﹤0.01% 7461
2022
Q4 		$11.6M Buy
2,130,045
+967,771
+83% +$5.93M ﹤0.01% 2622
2022
Q3 		$7.55M Sell
1,162,274
-169,068
-13% -$943K ﹤0.01% 3182
2022
Q2 		$6.3M Sell
1,331,342
-165,418
-11% -$815K ﹤0.01% 3386
2022
Q1 		$10.5M Buy
1,496,760
+1,477,221
+7,560% +$10.1M ﹤0.01% 2873
2021
Q4 		$199K Buy
+19,539
New +$210K ﹤0.01% 11862

Other funds holding MXCT

CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $481M AUM 73.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $128M AUM
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

Citadel Advisors's MXCT Position: Q2 2026 in Review

Citadel Advisors increased its MaxCyte (MXCT) stake by 157% in Q2 2026, buying an estimated $521K and bringing the position to 856,318 shares worth $1.05M. The position accounts for ﹤0.01% of the portfolio, ranked #8074.

Citadel Advisors first reported a position in MXCT in Q4 2021 and has held it in 19 quarters since. The position peaked at $11.6M in Q4 2022. 123 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

  • Citadel Advisors held 856,318 shares of MaxCyte worth $1.05M as of Q2 2026.
  • Citadel Advisors bought 523,230 MaxCyte shares in Q2 2026, an estimated $521K.
  • MaxCyte made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #8074 holding.
  • Citadel Advisors first reported a position in MaxCyte in Q4 2021 and has held it in 19 quarters since.
  • Citadel Advisors's MaxCyte position peaked at $11.6M in Q4 2022.
  • 123 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.